Preliminary experiences with a single-patient trials service in general practice

Medical Journal of Australia

Volumn 173, Issue 2, 2000, Pages 100-103

  Nikles, C Jane ^a   Glasziou, Paul P ^a   Del Mar, Chris B ^a   Duggan, Cate M ^a   Clavarino, Alexandra ^a   Yelland, Michael J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ADULT; AGED; ARTICLE; CHRONICITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENERAL PRACTICE; HUMAN; MALE; MEDICAL DECISION MAKING; OSTEOARTHRITIS; PAIN; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIAL; RIGIDITY;

EID: 0034679621     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2000.tb139254.x     Document Type: Article

References (11)

1. Richter JM. Approach to the patient with heartburn and reflux. In: Goroll AH, May LA, Mulley AG Primary care medicine, 3rd ed Philadelphia: Lippincott; 1995: 344-348.
2. Mahon JM, Laupacis A, Donner A, Wood T. Randomised study of n of 1 trials versus standard practice. BMJ 1996; 312: 1069-1074.
3. March L, Irwig L, Schwarz J, et al. n of 1 trials comparing a non-steroidal anti-inflammatory drug with paracetamol in osteoarthritis. BMJ 1994; 309: 1041-1045.
4. Sheather-Reid RB, Cohen ML. Efficacy of analgesics in chronic pain: a series of N-of-1 studies. J Pain Symptom Manage 1998; 15: 244-252.
5. Larson EB, Ellsworth AJ, Oas J. Randomised clinical trials in single patients during a 2-year period. JAMA 1993; 270: 2708-2712.
6. Guyatt GH, Keller JL, Jaeschke R, et al. The n-of-1 randomised controlled trial - clinical usefulness. Our three year experience. Ann Intern Med 1990; 112: 293-299.
7. Fries JF, Williams CA, Bloch DA, Michel BA. Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor models. Am J Med 1991; 91: 213-222.
8. Singh G. Recent considerations in nonsteroidal anti-inflammatory drug gastropathy. Am J Med 1998; 105 31S-38S.
9. Commonwealth of Australia. PBS statistics 1997-98. Insert in Schedule of Pharmaceutical Benefits fcr Approved Pharmacists and Medical Practitioners. Effective from 1 February 1999. Canberra: AGPS, 1999.
10. Walker JS, Sheather-Reid RB, Carmody JJ, et al. Nonsteroidal antiinflammatory drugs in rheumatoid arthritis and osteoarthritis: support for the concept of "responders" and "nonresponders". Arthritis Rheum 1997; 40: 1944-1954.
11. Hoyeraal HM, Fagertun H, Ingemann-Hansen T. et al. Characterisation of responders and nonresponders to tiaprofenic acid and naproxen in the treatment of patients with osteoarthritis. J Rheumatol 1993; 20: 1747-1752.